#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sjogren's syndrome Pulmonary fibrosis Ewing's sarcoma metastatic Synovial sarcoma recurrent Biliary cancer metastatic Cardiac arrest Homocystinuria Cystic fibrosis gastrointestinal disease Ependymoma Ureteric cancer Follicle centre lymphoma follicular grade I, II – III Familial hypertriglyceridaemia Ovarian cancer stage III Postprandial hypoglycaemia Neuropathic arthropathy More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Treatment Piriformis syndrome – Diagnostics Urea cycle disorder – Treatment Pemphigus – Basic Information Mantle cell lymphoma – Life with Disease Turner’s syndrome – Life with Disease Hereditary angioedema – Trials in Disease Haemophilia A without inhibitors – Trials in Disease Tuberous sclerosis complex – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phleum Pratense Pollen Extract Vindesine Sulfate Elotuzumab ATIRMOCICLIB Panobinostat Progesterone Ph. Eur. Cx-037231 Balstilimab Gd2Il18Cart Azd9550 At-1501 Iclepertin F44/10 Daptomycin Nimodipine Kyv-101 Trastuzumab Emtansine Macrogol 4000 Apraglutide Cabozantinib More therapies…

    Learn about Your Condition

    Osteoarthritis Pre-eclampsia Paedophilia Metachromatic leukodystrophy Binge eating Diabetic gastroparesis Myositis Parkinson's disease Kearns-Sayre syndrome Postoperative delirium Papilloma viral infection Rectal cancer recurrent Angiosarcoma metastatic Myofascial pain syndrome Abdominal pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Otorhinolaryngologic Diseases

  • Safety of injecting bupivacaine and dexamethasone into the parotid gland for patients undergoing surgery for a benign parotid tumor

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Salivary gland cancer
    Investigated Drugs:
    • Bupivacaine Hydrochloride
    • Epinephrine
    • Dexamethasone Acetate
    France

  • Effect of levothyroxine on kidney function in patients at risk of hypothyroidism after partial thyroid surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypothyroidism
    • Chronic kidney disease
    Investigated Drugs:
    • Levothyroxine
    Denmark

  • Comparing Two Treatment Lengths of Cetuximab, Avelumab, Cisplatin, and Docetaxel for Patients with Returning Spread Head and Neck Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer metastatic
    Investigated Drugs:
    • Avelumab
    • Cetuximab
    • Docetaxel
    Germany

  • Study of Mitazalimab Injection Treatment for Patients with High-Risk Oral Potentially Malignant Disorders

    Recruiting

    2 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Mitazalimab
    Italy

  • Study on Ropivacaine and Lidocaine for Reducing Pain After Tonsil Removal in Patients with Chronic Tonsillitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Tonsillitis
    Investigated Drugs:
    • BENZYDAMINE HYDROCHLORIDE
    • METAMIZOLE SODIUM
    • Pantoprazole
    Austria

  • Study on How Mepolizumab Affects Patients with Chronic Rhinosinusitis with Nasal Polyps

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Mepolizumab
    The Netherlands
1 2 3 … 11
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!